Baltimore, Maryland
CNS clinical trials in Baltimore, MD
59 CNS studies are recruiting participants at sites in Baltimore as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Baltimore at a glance
- 59 studies are recruiting at a site in Baltimore.
- By phase: Early Phase 1 (1), Phase 1 (5), Phase 1/2 (1), Phase 2 (6), Phase 3 (16), Phase 4 (6), No phase (16), Observational (8). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (30), industry (26), government (3).
- By research area: Depression (16), Parkinson's Disease (14), Multiple Sclerosis (10), ADHD (5), Epilepsy (5), Schizophrenia (5), Migraine (3), Bipolar Disorder (1).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Baltimore
Basic details from each study's public record (the 30 most recently updated of 59). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Study site
- Sheppard Pratt Health System, Inc.
- Registry record
- NCT03887715 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Kaiser Permanente-Woodlawn Medical Center · Maryland Proton Treatment Center · MedStar Franklin Square Medical Center/Weinberg Cancer Institute
- Registry record
- NCT06748222 · updated
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Pharmasite Research, Inc.
- Registry record
- NCT07412756 · updated
Defining Neurobiological Links Between Substance Use and Mental Illness
- No phase
- Ages 18 to 60
- All sexes
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Study site
- National Institute on Drug Abuse
- Registry record
- NCT05538910 · updated
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Johns Hopkins University
- Registry record
- NCT07227454 · updated
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Pharmasite Research, Inc.
- Registry record
- NCT07573176 · updated
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Pharmasite Research, Inc.
- Registry record
- NCT07775300 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Baltimore, MD on ClinicalTrials.gov.
Schizophrenia studies recruiting in Baltimore
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
- No phase
- Ages 18 to 59
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- University of Maryland, Baltimore
- Registry record
- NCT07853807 · updated
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- University of Maryland, Baltimore
- Study site
- University of Maryland
- Registry record
- NCT05440214 · updated
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- The Johns Hopkins Hospital
- Registry record
- NCT07101094 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Baltimore, MD on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Baltimore
The COSMYC Trial (COmbined Suppression of MYC)
- Phase 2
- Ages 18 and older
- Male participants
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Study site
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
- Registry record
- NCT06922318 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Baltimore, MD on ClinicalTrials.gov.
ADHD studies recruiting in Baltimore
The Myelin Disorders Biorepository Project
- Observational
- All ages
- All sexes
- Sponsor
- Children's Hospital of Philadelphia
- Study site
- Kennedy Krieger Institute
- Registry record
- NCT03047369 · updated
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- Kennedy Krieger Institute
- Registry record
- NCT04781140 · updated
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- Phase 4
- Ages 8 to 12
- All sexes
- Sponsor
- Donald Gilbert, MD, MS, FAAN, FAAP
- Study site
- Kennedy Krieger Institute
- Registry record
- NCT04421248 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Baltimore, MD on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Baltimore
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06989112 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study sites
- MedStar Franklin Square Medical Center ( Site 0031) · MedStar Good Samaritan Hospital ( Site 0079)
- Registry record
- NCT06841354 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Mercy Medical Center - Baltimore ( Site 0015)
- Registry record
- NCT06966700 · updated
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
- Phase 2
- Ages 50 to 80
- All sexes
- Sponsor
- Yale University
- Study site
- Johns Hopkins University
- Registry record
- NCT06996652 · updated
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Phase 3
- Ages 45 to 75
- All sexes
- Sponsor
- BlueRock Therapeutics
- Study site
- Johns Hopkins Hospital - Neurology
- Registry record
- NCT06944522 · updated
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Phase 2
- Ages 40 to 80
- All sexes
- Sponsor
- Neuron23 Inc.
- Study site
- University of Maryland
- Registry record
- NCT06680830 · updated
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Greenebaum Comprehensive Cancer Center ( Site 0036)
- Registry record
- NCT06312176 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Baltimore, MD on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Baltimore
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Johns Hopkins University/Sidney Kimmel Cancer Center
- Registry record
- NCT03816345 · updated
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- Phase 2
- Ages 18 to 60
- All sexes
- Sponsor
- Johns Hopkins University
- Study site
- Johns Hopkins University
- Registry record
- NCT07497399 · updated
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT06433752 · updated
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Sanofi
- Study site
- Baltimore Veterans Affairs Medical Center- Site Number : 8400163
- Registry record
- NCT07325292 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Baltimore, MD on ClinicalTrials.gov.
Epilepsy studies recruiting in Baltimore
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Phase 3
- Ages 4 to 55
- All sexes
- Sponsor
- SK Life Science, Inc.
- Study site
- Johns Hopkins Hospital
- Registry record
- NCT05219617 · updated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study sites
- MedStar Franklin Square Medical Center · University of Maryland Medical Center
- Registry record
- NCT05667142 · updated
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- Johns Hopkins University
- Registry record
- NCT06798896 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Baltimore, MD on ClinicalTrials.gov.
Migraine studies recruiting in Baltimore
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- H. Lundbeck A/S
- Study site
- University of Maryland School of Medicine
- Registry record
- NCT05164172 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Pharmasite Research, Inc. /ID# 227908
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Baltimore, MD on ClinicalTrials.gov.
Ask about studies near Baltimore
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Maryland
All Maryland locations
144 studies recruiting across 21 cities.
Bethesda
54 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections